Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
How Low Could Semaglutide Prices Fall? An Analysis of Production Cost and Implications for Global Access
Levi J, Cross S, Ramesh N, et al.
Obesity (Silver Spring, Md.), 2026
TAAR1 as a Potential Alternate Molecular Target to GLP-1 for Novel Anti-diabetic, Anti-obesity Medications
Lenham RK, Elgammal F, Harding SV, et al.
Handbook of experimental pharmacology, 2026
Semaglutide alters behaviour and nucleus accumbens oscillatory activity in healthy mice
Mosqueira A, Ansarifar S, Nabavi S, et al.
Molecular brain, 2026
The Periprocedural Safety of Continued GLP-1 Receptor Agonist Prior to Cardiac Catheterization
Chi KY, Adhikari S, Chang Y, et al.
The American journal of cardiology, 2026
Pharmacologic Treatment for Obstructive Sleep Apnea in Older Adults
Jaganathan N, Brower D, Healy WJ
Drugs & aging, 2026
Lower fall and femoral fracture risks with semaglutide and tirzepatide compared with DPP-4 inhibitors in older adults with type 2 diabetes
Chen HY, Wu JY, Chu YH, et al.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2026
Tirzepatide compared with semaglutide in obesity disease: a subpopulation analysis applying Japan Society for the Study of Obesity criteria in the global SURMOUNT-5 trial
Kitamoto T, Yoshino M, Shingaki T, et al.
Current medical research and opinion, 2026;:1-13
Tirzepatide Attenuates Wire Injury-Induced Arterial Remodeling in Non-Diabetic and Diabetic Mice: Comparison with Semaglutide
Mori Y, Osaka N, Terasaki M, et al.
Biomedicines, 2026;14(7)
What the Scale Does Not Show: A Patient’s Reflection on Semaglutide, Strength, and the SMART Trial
Schumacher E
Clinical journal of the American Society of Nephrology : CJASN, 2026
Influence without medical expertise: a social network analysis of Mounjaro discussions on twitter (X)
AlHazmi S, AlRasheed HA, Gomaa B
Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2026;34(4)
Déjà vu! A Case of Recurrent Metabolic Dysfunction-Associated Steatohepatitis 70 Days After Liver Transplantation
Still M, Gettelfinger A, Akinditan V, et al.
ACG case reports journal, 2026;13(7):e02232
Partially reversible bilateral non-arteritic anterior ischemic optic neuropathy and branch retinal artery occlusion following semaglutide use. a case report
Alsakran WA, Alkhaldi HM, Magliyah MS
BMC ophthalmology, 2026
Semaglutide cardiovascular outcomes align more closely with attained dose than achieved weight loss
Murugadoss K, Venkatakrishnan AJ, Gregg CJ, et al.
NPJ cardiovascular health, 2026
Understanding the effects of ciprofloxacin on corneal epithelial cells: a study using electric cell-substrate impedance sensing (ECIS) technology
Banga L, Shawky M, Ebrahim F, et al.
Experimental eye research, 2026;:111162
Severe Perioperative Lactic Acidosis and Hyperglycemia Responsive to Thiamine in a Patient With Prior Semaglutide Use and Restrictive Dieting: A Case Report
Kataria S, Pylypiv O, Fahrenkrog M
A&A practice, 2026;20(7):e02253
Semaglutide in Diabetic Periodontitis-Induced Osteoblast Ferroptosis: Pharmacological and Methodological Insights [Letter]
Dong Y
Drug design, development and therapy, 2026;20:637327
Semaglutide-Induced Ischemic Colitis in A Middle-Aged Female Without Vascular Risk Factors
Joma M, Karam AM, Sayeh W, et al.
European journal of case reports in internal medicine, 2026;13(7):006649
GLP-1 receptor agonists in multiple sclerosis: a systematic review of preclinical and clinical evidence
Sajjad M, Sajjad A, Amer R, et al.
Multiple sclerosis and related disorders, 2026;113:107388
Real-world treatment satisfaction and experience with once-weekly tirzepatide: Insights from prescribing physicians and people with obesity or overweight
Gibble TH, Leith A, Harrison L, et al.
Obesity pillars, 2026;19:100300
Tirzepatide and the gut microbiota-obesity axis: metabolic mechanisms and therapeutic perspectives
Cadena-Ullauri S, Cadena Paredes AS, Guamán-Herrera L, et al.
Frontiers in microbiology, 2026;17:1901528